Developing a Robust and Scalable CGMP Protein Manufacture Process
September 12, 2014
This podcast features:
Daniel Smith, PhD, chief scientific officer of Cobra Biologics, and Julian Hanak, commercial director of Cobra Biologics
This podcast was recorded at the 2014 BioProcess Theater which took place at the 2014 BIO International Convention, June 23-26, 2014. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.
The 2014 BioProcess Theater consisted of five main presentation tracks: Antibody-Drug Conjugates, Single-Use Processing, Upstream Processing, Manufacturing, and Cell Therapies.
If you would like more information on these presentations, please email us: [email protected]
You May Also Like